Humana Inc. Files 8-K with Regulation FD Disclosure

Ticker: HUM · Form: 8-K · Filed: 2024-03-05T00:00:00.000Z

Sentiment: neutral

Topics: disclosure, regulation-fd

TL;DR

Humana filed an 8-K today - standard disclosure, no major news yet.

AI Summary

On March 5, 2024, Humana Inc. filed an 8-K report. The filing indicates a Regulation FD Disclosure, meaning it contains material information that may be of interest to investors. No specific financial transactions or material events were detailed in the provided excerpt, but the filing itself is a standard disclosure mechanism.

Why It Matters

This filing serves as a public notification of material information, ensuring transparency for investors and the market regarding Humana Inc.'s disclosures.

Risk Assessment

Risk Level: low — The filing is a routine disclosure and does not contain information indicating significant new risks or changes.

Key Numbers

Key Players & Entities

FAQ

What specific information is being disclosed under Regulation FD?

The provided excerpt does not detail the specific content of the Regulation FD disclosure, only that the filing is intended to satisfy this requirement.

When was the earliest event reported in this 8-K filing?

The earliest event reported is March 5, 2024.

What is Humana Inc.'s principal executive office address?

Humana Inc.'s principal executive offices are located at 500 West Main Street, Louisville, Kentucky 40202.

What is Humana Inc.'s telephone number?

Humana Inc.'s telephone number is (502) 580-1000.

What is the Standard Industrial Classification code for Humana Inc.?

The Standard Industrial Classification code for Humana Inc. is 6324, which corresponds to Hospital & Medical Service Plans.

From the Filing

0000049071-24-000015.txt : 20240305 0000049071-24-000015.hdr.sgml : 20240305 20240305073015 ACCESSION NUMBER: 0000049071-24-000015 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240305 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20240305 DATE AS OF CHANGE: 20240305 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANA INC CENTRAL INDEX KEY: 0000049071 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 610647538 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-05975 FILM NUMBER: 24718281 BUSINESS ADDRESS: STREET 1: 500 W MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 BUSINESS PHONE: 5025801000 MAIL ADDRESS: STREET 1: 500 W. MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 FORMER COMPANY: FORMER CONFORMED NAME: EXTENDICARE INC DATE OF NAME CHANGE: 19740404 FORMER COMPANY: FORMER CONFORMED NAME: HERITAGE HOUSE OF AMERICA INC DATE OF NAME CHANGE: 19671129 8-K 1 hum-20240305.htm 8-K hum-20240305 0000049071 false 0000049071 2024-03-05 2024-03-05 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 5, 2024 ( March 5, 2024 ) Humana Inc. (Exact name of registrant as specified in its charter) Delaware 001-5975 61-0647538 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 500 West Main Street , Louisville , Kentucky 40202 (Address of principal executive offices, including zip code) ( 502 ) 580-1000 (Registrant’s telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock HUM New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐ Item 7.01 Regulation FD Disclosure. Members of Humana Inc.’s (the “Company”) senior management team are scheduled to meet with investors and analysts at an industry conference and various other meetings between March 5, 2024 and March 31, 2024. During these meetings, the Company intends to reaffirm its guidance of approximately $14.87 in diluted earnings per common share (“EPS”), or approximately $16.00 in adjusted earnings per common share (“Adjusted EPS”), in each case for the year ending December 31, 2024 (“FY 2024”). This guidance is consistent with the guidance issued in Humana’s press release dated January 25, 2024. The date and time of presentations to investors are available via the Investor Relations calendar of eve

View on Read The Filing